$42.7 Million
Xeris Pharmaceuticals, Inc.
Follow-On Offering
Active Bookrunner
$201.3 Million
Deciphera Pharmaceuticals, Inc.
Follow-On Offering
Active Bookrunner
$266.8 Million
Arrowhead Pharmaceuticals, Inc.
Follow-On Offering
Active Bookrunner
$315.2 Million
CRISPR Therapeutics AG
Follow-On Offering
Active Bookrunner
$172.3 Million
NextCure, Inc.
Follow-On Offering
Active Bookrunner
$230.0 Million
Natera, Inc.
Follow-On Offering
Active Bookrunner
$460.0 Million
Deciphera Pharmaceuticals, Inc.
Follow-On Offering
Active Bookrunner
$322.6 Million
Biohaven Pharmaceutical Holding Company Ltd.
Follow-On Offering
Active Bookrunner
$69.0 Million
ASLAN Pharmaceuticals Pte. Ltd.
Follow-On Offering
Active Bookrunner
$125.0 Million
Biohaven Pharmaceutical Holding Company Ltd.
Follow-On Offering
Active Bookrunner
Subscribe to Active Bookrunner

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.